Abstract. The mechanism to enhance nerve growth factor (NGF, 2 ng / ml)-induced neurite outgrowth from PC12D cells by nardosinone isolated from Nardostachys chinensis was examined. It was shown that the potentiation of the NGF-induced neurite outgrowth by nardosinone was mitogen-activated protein (MAP) kinase-dependent, but was not accompanied by stimulation of NGF-induced increase in MAP kinase phosphorylation. Furthermore, this augmentation of NGF-induced neurite outgrowth was abolished by GF109203X, a protein kinase C (PKC) inhibitor. These results suggest that the enhancement of NGF-induced neurite outgrowth from PC12D cells by nardosinone involves activation of a down-stream step of the MAP kinase-dependent cascade of NGF coupled with PKC.
Several neurotrophic factors, including NGF have held the promise of therapeutic efficacy in the treatment of dementia. NGF has potential for treatment of Alzheimer's disease and other neurodegenerative disorders, including peripheral neuropathy. However, NGF is a polypeptide, does not cross the blood-brain barrier, and is metabolized by peptidases when administered peripherally. A useful strategy of addressing this problem is to administer drugs that either enhance the action of endogenous neuritogenic substances such as NGF or increase the expression of these substances in the central nervous system (1) . Oral administration of Tokishakuyaku-san, a Chinese traditional medicine, has been reported to increase NGF content in olfactory-bulblesioned mice (2) . Several synthetic compounds (3 -5) and natural products (6 -8) have been shown to enhance the action of NGF in neurite outgrowth from PC12 cells. Recently, we have isolated nardosinone as a natural compound potentiating the neurite outgrowth-inducing activity of NGF from Nardostachys chinensis (9) . In the present study, we for the first time demonstrated that nardosinone enhanced neurite outgrowth-inducing action of NGF by activating the signaling pathway via mitogen-activated protein (MAP) kinase and protein kinase C (PKC).
Nardosinone was isolated from Nardostachys chinensis as previously reported (9) . For all experiments, nardosinone was dissolved in dimethyl sulfoxide (DMSO), and the concentration of DMSO was kept at less than 0.1%. PC12D cells, a subclone of a rat pheochromocytoma cell line (PC12 cells), were maintained at 37°C in a humidified atmosphere of 5% CO 2 and 95% air in a high glucose (4.5 g / l)-containing Dulbecco's modified Eagle's medium (DMEM) supplemented with 5% fetal calf serum, 10% horse serum, and 2 mM glutamine (9) . Since heterogeneity of PC12 subclones sometimes causes serious problems, such as differences in the response to chemical agents as well as in morphology, we used the PC12D clone to minimize the problems. For scanning electron microscopy, cells were dissociated by incubation with 1 mM EGTA in phosphate-buffered saline (PBS) for 1 h and were grown on 35-mm-diameter culture dishes coated with poly-Llysine (Sigma Chemical Co., St. Louis, MO, USA). After 24 h, the medium was changed to an appropriate test medium supplemented with 1% fetal calf serum and 2% horse serum. Forty-eight hours later, cells were washed once with serum-free DMEM, fixed with 2% glutaraldehyde (Wako Pure Chemical, Tokyo) in 0.1 M PBS at pH 7.2 for 20 min at room temperature and then washed twice with 0.1 M PBS at pH 7.2. The fixed PC12D cells were immersed in the buffer solution containing 2.5% glutaraldehyde and 0.1% tannic acid for 20 min. Thereafter, the desired PC12D cells were isolated in the phosphate buffer, dehydrated through a graded alcohol series, and then dried using a t-butyl alcohol freeze drier (ES-2030; Hitachi, Tokyo). The dried specimen was platinum-palladium coated using an ion-coater (E1030, Hitachi). Using a scanning electron microscope (S-4500, Hitachi), the secondary electron images were obtained with an accelerating voltage of 10 kV. Measurement of NGF action-potentiating activity in PC12D cells using a phase-contrast microscope were also performed as previously reported (9) . Processes with lengths equivalent to one or more diameters of a cell body were scored as neurites. The potentiation of NGF action was assessed by examining the proportion of neurite-bearing cells to total cells (at least 100 cells) in the randomly selected areas. For treatment with PD98059, a potent MAP kinase kinase inhibitor or GF109203X, a PKC inhibitor, each inhibitor was added to an appropriate test medium described above, and then the culture medium was changed to the test medium containing each inhibitor. After 48 h, each culture was fixed with 2% glutaraldehyde in PBS and stored in PBS solution.
For Western blot analysis, PC12D cells were plated as described previously (9) and treated with or without nardosinone (100 mM) in the presence or absence of NGF. For treatment with PD98059, medium change was carried out as described above. Cells were treated with PD98059 for 10 min. Following washing cells with icecold PBS, cells were subjected to Western blot analysis. Western blot analysis using anti-active MAP kinase 1 / 2 antibody (Promega, Madison, WI, USA)) was performed as described previously (7).
The data were expressed as the mean ± S.E.M. Statistically significant difference was determined by one-way analysis of variance (ANOVA). P<0.05 was considered significant.
Recently, it has been found that nardosinone potentiates the neurite outgrowth-inducing activity of NGF in PC12D cells by our phase-contrast microscopic analysis (9). Here we in more detail examined the potentiating effect of nardosinone on the neurite outgrowth-inducing activity of NGF using a scanning electron microscope. A comparison of electron micrographs of neurites from PC12D cells by treatment with or without NGF in the presence or absence of nardosinone is shown in Fig. 1 . Naive PC12D cells were generally round to ovoid with numerous large blebs and microvilli on the surface of the cells (Fig. 1A) , while 100 mM nardosinone had no effect on the surface morphology of PC12D cells (Fig. 1C) . Small dendrites were observed in PC12D cells treated with 2 ng / ml NGF (Fig. 1B) . In PC12D cells cultured in the presence of 100 mM nardosinone together with 2 ng / ml NGF, in addition to small dendrites, long neurites with growth cones were observed (Fig. 1D ). When treated with 30 ng / ml NGF, PC12D cells had many dendrites and long neurites with growth cones (Fig. 1E) .
To elucidate the mechanism by which nardosinone potentiates the NGF-induced neurite outgrowth from PC12D cells, the effects of PD98059 and GF109203X on the enhancement of NGF-induced neurite outgrowth by nardosinone was next examined. The nardosinoneinduced potentiation of neurite outgrowth from PC12D cells cultured in the presence of 2 ng / ml NGF was completely inhibited by 3 m M PD98059 ( Fig. 2A) , while the potentiation of NGF-induced neurite outgrowth by nardosinone was inhibited by GF109203X (Fig. 2B ) in a concentration-dependent manner and was abolished at 30 nM GF109203X, suggesting the involvement of MAP kinase and PKC in the enhancement of NGFinduced neurite outgrowth by nardosinone.
Phosphorylation of both the tyrosine and threonine residues of MAP kinase 1/ 2 by MAP kinase kinase is required for the full enzymatic activation (10) . Since the enhancement of NGF-induced neurite outgrowth by nardosinone was shown to be abolished by PD98059 as shown in Fig. 2A , Western blot analysis was performed to examine the effect of nardosinone on the dual phosphorylation of MAP kinase. Nardosinone alone almost had no effect on the phosphorylation of MAP kinase 1 / 2 ( Fig. 2D: lanes 1 and 3) . Unexpectedly, this natural compound did not enhance NGF-stimulated phosphorylation of MAP kinase 1 / 2, which was inhibited by PD98059 ( Fig. 2C: lanes 2, 4, and 5 ). The findings from the present electron microscopic analysis demonstrated that nardosinone caused a marked enhancement of neurite outgrowth induced by a low concentration of NGF. Furthermore, we here provided the first evidence that nardosinone enhanced the NGFinduced neurite outgrowth without affecting NGFstimulated phosphorylation of MAP kinase 1 / 2, and that the enhancement of NGF-induced neurite outgrowth by nardosinone required activation of the signaling cascade mediated by both MAP kinase and protein kinase C. It has been shown that NGF activates MAP kinase (11) and that MAP kinase-dependent and -independent pathways are involved in the NGF receptormediated intracellular signaling pathway for the process formation of NGF-treated PC12 cells (7, 9, 11 -14) . Our earlier report has shown that 3 m M PD98059 abolishes the nardosinone-induced potentiation of neurite outgrowth from PC12D cells cultured in the presence of 2 ng / ml NGF, but did not affect the neurite outgrowth from PC12D cells cultured in the presence of 2 ng / ml NGF alone (9) , which is consistent with the finding described in Fig. 2A, indicating that NGF alone appears not to activate the MAP kinase cascade at the concentration of 2 ng / ml, whereas in the presence of nardosinone, the same concentration of NGF seems to enhance the MAP kinase cascade to induce the neurite outgrowth from PC12D cells in a MAP kinase-dependent manner. Furthermore, in the present study, the potentiation of NGF-induced neurite outgrowth by nardosinone was shown to be inhibited by GF109203X in a concentration-dependent manner and be abolished at 30 nM GF109203X. A very important finding in the present study is that such a nardosinone-activated and MAP kinase-dependent component controlling NGFinduced neurite outgrowth requires a PKC-mediated signaling pathway. This finding, taken together with the reported observation that PKC is required for NGFactivation of the MAP kinase cascade involved in neurite outgrowth from PC12 cells (15) , raises the possibility of cross-talk between MAP kinase cascade and an as-yet-unidentified PKC isoform-mediated pathway for promoting neurite outgrowth by nardosinone, although the issue of what isoform(s) of PKC is expressed in PC12D cells remains to be addressed. The present Western blot analysis also showed that nardosinone did not enhance NGF-stimulated phosphorylation of MAP kinase 1 / 2. Therefore, the results of this study suggest that nardosinone enhances a down-stream step of MAP kinase in the MAP kinase-dependent signaling pathway coupled with PKC. Nardosinone may thus provide a useful pharmacological tool to clarify the mechanism of signal transduction controlling the NGFinduced neurite outgrowth from PC12D cells.
